提升与调动ICU患者代理决策者的健康与情绪韧性(EMPOWER):一项随机对照试验的研究方案
危重疾病增加患者及其非正式照护者(尤其是代理决策者)出现不良心理健康结局的风险。EMPOWER是一项在ICU环境中提供给代理决策者的新型认知行为、基于接纳的干预,旨在改善患者的生活质量与死亡质量以及代理决策者的心理健康。研究将先用临床利益相关者和代理参与者反馈(n=15)及开放试验(n=10)结果优化干预,再通过多中心随机对照试验(n=60)评估其相对于常规照护的临床优效性。
要点
- EMPOWER是面向ICU患者代理决策者的认知行为、基于接纳的干预,目标为改善患者生活质量与死亡质量及代理者心理健康。
- 将用临床利益相关者和代理参与者反馈(n=15)及开放试验(n=10)结果优化干预。
- 通过多中心随机对照试验(n=60)评估EMPOWER相对于常规照护的临床优效性。
核心结论
- EMPOWER研究独特地将针对围创伤性应激的循证心理治疗应用于危重疾病情境,以改善患者和照护者的结局。
- 随机对照试验结果将投稿至同行评审期刊,并作为申请更大规模多中心随机对照试验基金的初步数据。
研究设计与样本
- 研究方案为多中心随机对照试验(n=60),将EMPOWER与常规照护进行比较以检验临床优效性。
- 干预优化基于临床利益相关者和代理参与者反馈(n=15)以及开放试验(n=10)的结果。
- 可行性、耐受性和可接受性通过自我报告评估;采用分层线性模型校正干预者内聚类。
- 主要结局为围创伤性应激的代理决策者差异;次要结局包括创伤后应激障碍症状、延长哀伤障碍和体验性回避。
- 探索性结局包括焦虑、抑郁和决策后悔症状,均在干预后评估后1个月和3个月测量。
局限性
- 试验注册为回顾性注册(ClinicalTrials.gov,NCT03276559,2017年9月8日回顾性注册)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critical illness increases the risk for poor mental health outcomes among both patients and their informal caregivers, especially their surrogate decision-makers. Surrogates who must make life-and-death medical decisions on behalf of incapacitated patients may experience additional distress. EMPOWER (Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience) is a novel cognitive-behavioral, acceptance-based intervention delivered in the intensive care unit (ICU) setting to surrogate decision-makers designed to improve both patients' quality of life and death and dying as well as surrogates' mental health. METHODS: Clinician stakeholder and surrogate participant feedback (n = 15), as well as results from an open trial (n = 10), will be used to refine the intervention, which will then be evaluated through a multisite randomized controlled trial (RCT) (n = 60) to examine clinical superiority to usual care. Feasibility, tolerability, and acceptability of the intervention will be evaluated through self-report assessments. Hierarchical linear modeling will be used to adjust for clustering within interventionists to determine the effect of EMPOWER on surrogate differences in the primary outcome, peritraumatic stress. Secondary outcomes will include symptoms of post-traumatic stress disorder, prolonged grief disorder, and experiential avoidance. Exploratory outcomes will include symptoms of anxiety, depression, and decision regret, all measured at 1 and 3 months from post-intervention assessment. Linear regression models will examine the effects of assignment to EMPOWER versus the enhanced usual care group on patient quality of life or quality of death and intensity of care the patient received during the indexed ICU stay assessed at the time of the post-intervention assessment. Participant exit interviews will be conducted at the 3-month assessment time point and will be analyzed using qualitative thematic data analysis methods. DISCUSSION: The EMPOWER study is unique in its application of evidence-based psychotherapy targeting peritraumatic stress to improve patient and caregiver outcomes in the setting of critical illness. The experimental intervention will be strengthened through the input of a variety of ICU stakeholders, including behavioral health clinicians, physicians, bereaved informal caregivers, and open trial participants. Results of the RCT will be submitted for publication in a peer-reviewed journal and serve as preliminary data for a larger, multisite RCT grant application. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03276559 . Retrospectively registered on 8 September 2017.
引用
- Prigerson HG, Viola M, Brewin CR, et al. Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience (EMPOWER) among Surrogate Decision-Makers of ICU Patients: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31288829. doi:10.1186/s13063-019-3515-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。